Type III kuddel muddel [🇷 for BE/BA]

posted by Helmut Homepage – Vienna, Austria, 2015-06-12 13:27 (4021 d 17:16 ago) – Posting: # 14948
Views: 17,396

Dear Detlew & all,

❝ WinNonlin/Phoenix uses a different form of F-Tests (not based on Type III sos) AFAIK.


Yes. An excerpt of the manual here and an example there. There is no guaran­tee that Phoenix/WinNonlin and SAS will be that close in all cases.

❝ So what can we suggest to Yung-jin w.r.t. the ANOVA?

❝ SAS way, Phoenix way, R's drop1() (which doesn't work for sequence) or what else?


Duno. We explored package lsmeans in this lengthy thread without a final con­clusion. For the R-com­mu­nity’s “dogma” see Venables’ paper* (section 5).

❝ […] the primary concern, the 90% CI as bioequivalence measure doesn't depend in any way from such considerations. Thank goodness!


:ok:

❝ But regulators like to see some sort of effect tests in the ANOVA. Which one is their secret


I would rather say “[…] by which software and/or coding is their secret”. I never gave anything but the PE and CI in the main text of my reports (the complete eva­lu­ation only in the appendix). Although some assessors or inspectors routinely re­cal­cu­late studies (in SAS or in the semi-secret WinBE?) I never received a ques­tion. Maybe they compared only the CI, which – as you said – is the only relevant part.

When it comes to the type III stuff I gather that it will be practically impossible (e.g., Phoenix/WinNonlin) or difficult (R?) to exactly reproduce SAS’ results. AFAIK only SPSS uses the same algo as SAS.



PS: Kuddelmuddel ~ hash, jumble, mess…


Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
130 visitors (0 registered, 130 guests [including 16 identified bots]).
Forum time: 06:44 CEST (Europe/Vienna)

Always listen to experts.
They’ll tell you what can’t be done and why.
Then do it.    Robert A. Heinlein

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5